Keros Therapeutics Cash Flow Statement (2019-2025) | KROS

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Operating Activities
Net Income (Quarter)	-15.88M	-15.62M	-20.30M	-6.94M	-24.19M	-27.27M	-23.51M	-29.72M	-39.37M	-91.44M	-76.88M	-45.58M	-43.11M	-45.26M	-52.96M	-46.03M	148.45M	-30.70M	-7.28M	-23.46M
Depreciation and Depletion (Quarter)	0.08M	0.09M	0.10M	0.10M	0.11M	0.31M	0.13M	0.13M	0.17M	0.19M	0.21M	0.25M	0.28M	0.30M	0.32M	0.33M	0.34M	0.37M	0.40M	0.40M
Share-based Compensation (Quarter)	2.49M	2.85M	3.08M	3.29M				15.42M	1.34M	11.39M	-11.39M		8.07M	8.79M	8.82M	9.20M	8.86M	8.54M	-17.41M
Cash from Operations (Quarter)	-10.51M	-17.64M	-14.44M	-19.57M	-1.43M	-22.59M	-24.60M	-21.44M	-34.23M	-30.83M	-33.98M	-25.46M	-44.56M	-39.80M	-30.50M	-46.01M	161.17M	-29.62M	3.25M	-27.29M
Depreciation, Depletion & Amortization
Amortization of Deferred Charges (Quarter)	0.10M	0.10M	0.12M	0.20M	0.20M	0.21M	0.21M	0.32M	0.52M	0.35M	0.34M	0.34M	0.34M	0.35M	0.56M	0.57M	0.58M	0.59M	0.61M	0.62M
Depreciation & Amortization (CF) (Quarter)	0.08M	0.09M	0.10M	0.10M	0.11M	0.31M	0.13M	0.13M	0.17M	0.19M	0.21M	0.25M	0.28M	0.30M	0.32M	0.33M	0.34M	0.37M	0.40M	0.40M
Change in Working Capital
Change in Receivables (Quarter)		0.10M	-0.10M	18.00M	-18.00M							0.14M	0.08M	-0.22M	0.38M	2.35M	14.55M	-1.48M	-12.32M	0.07M
Change in Account Payables (Quarter)	0.86M	-1.64M	1.44M	0.82M	-0.67M	4.66M	-4.99M	0.59M	1.32M	-0.57M	-0.18M	1.04M	0.02M	1.61M	-1.59M	-0.29M	2.02M	-1.37M	-2.96M	-0.70M
Change in Accured Expenses (Quarter)	0.89M	0.20M	1.65M	-0.10M	0.36M	-0.58M	1.28M	4.26M	-1.98M	1.17M	0.27M	5.79M	-5.35M	0.90M	8.71M	-1.30M	-3.58M	2.67M	-4.79M	-4.43M
Change in Taxes (Quarter)																	10.04M	-3.72M	-2.17M
Other Working Capital Changes (Quarter)	-1.07M	3.42M	-2.35M	1.55M	-0.76M	4.10M	-0.29M	-1.48M	4.07M	1.49M	-5.56M	9.28M		10.84M	-11.31M	10.68M	-1.59M	-0.46M	-1.82M	1.82M
Investing Activities
Capital Expenditures (Quarter)	0.21M	-0.21M	0.86M	0.16M	0.09M	0.63M	-0.70M	0.06M	0.02M	1.35M	0.55M	0.54M	0.23M	1.03M	0.39M	0.29M	0.56M	0.72M	-1.28M	1.55M
Cash from Investing Activities (Quarter)	-0.21M	-0.51M	-0.14M	-0.16M	-0.15M	-0.57M	-0.18M	-0.35M	-1.06M	-0.31M	-0.55M	-0.54M	-0.95M	-0.31M	-0.39M	-0.29M	-0.56M	-0.72M	-0.13M	-0.13M
Financing Activities
Other financing activities (Quarter)	0.04M	0.06M	0.04M	0.24M	0.12M	0.50M	0.10M	0.10M	0.37M	1.74M	0.31M	0.80M	5.72M	2.97M	1.01M	2.44M	0.00M	0.02M	0.00M	0.12M
Cash from Financing Activities (Quarter)	0.04M	0.06M	0.04M	28.42M	0.12M	10.19M	48.58M	61.42M	107.68M	1.74M	0.28M	69.25M	156.80M	3.53M	155.94M	75.54M	0.00M	0.02M	0.14M	-378.63M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)				28.17M		9.69M	48.49M	-58.18M	107.31M			68.52M	151.34M		4.36M	72.91M
Additional items
Change in Cash (Quarter)	-10.67M	-18.09M	-14.55M	8.69M	-1.46M	-12.96M	23.80M	39.62M	72.38M	-29.40M	-34.25M	43.25M	111.30M	-36.58M	125.06M	29.25M	160.61M	-30.33M	3.26M	-406.06M
Free Cash Flow (Quarter)	-10.71M	-17.43M	-15.31M	-19.72M	-1.51M	-23.22M	-23.90M	-21.50M	-34.26M	-32.18M	-34.53M	-26.00M	-44.79M	-40.83M	-30.89M	-46.30M	160.61M	-30.34M	4.53M	-28.84M
Net Cash Flow (Quarter)	-10.67M	-18.09M	-14.55M	8.69M	-1.46M	-12.96M	23.80M	39.62M	72.38M	-29.40M	-34.25M	43.25M	111.30M	-36.58M	125.06M	29.25M	160.61M	-30.33M	3.26M	-406.06M

Research Tools

Developers

Keros Therapeutics Cash Flow Statement (2019-2025) | KROS

Research Tools

Developers

Keros Therapeutics Cash Flow Statement (2019-2025) | KROS

Create an account

Sign In

Reset Password